Log in to save to my catalogue

TLR5 is a new reporter for triple‐negative breast cancer indicated by radioimmunoimaging and fluores...

TLR5 is a new reporter for triple‐negative breast cancer indicated by radioimmunoimaging and fluores...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6850942

TLR5 is a new reporter for triple‐negative breast cancer indicated by radioimmunoimaging and fluorescent staining

About this item

Full title

TLR5 is a new reporter for triple‐negative breast cancer indicated by radioimmunoimaging and fluorescent staining

Publisher

England: John Wiley & Sons, Inc

Journal title

Journal of cellular and molecular medicine, 2019-12, Vol.23 (12), p.8305-8313

Language

English

Formats

Publication information

Publisher

England: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Triple‐negative breast cancer (TNBC) is a highly aggressive tumour that lacks marker for targeted diagnosis. Recently, it was reported that toll‐like receptor 5 (TLR5) was associated with some kind of tumours, especially in TNBC, but whether it could be used as a non‐invasive monitoring target is not fully understood. Here, we established TLR5− 4T1...

Alternative Titles

Full title

TLR5 is a new reporter for triple‐negative breast cancer indicated by radioimmunoimaging and fluorescent staining

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6850942

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6850942

Other Identifiers

ISSN

1582-1838,1582-4934

E-ISSN

1582-4934

DOI

10.1111/jcmm.14707

How to access this item